Valley National Advisers’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$73K Sell
164
-1
-0.6% -$445 0.01% 342
2025
Q1
$79K Buy
165
+43
+35% +$20.6K 0.01% 321
2024
Q4
$49K Hold
122
0.01% 359
2024
Q3
$56K Sell
122
-39
-24% -$17.9K 0.01% 346
2024
Q2
$75K Buy
161
+10
+7% +$4.66K 0.01% 340
2024
Q1
$63K Sell
151
-23
-13% -$9.6K 0.01% 378
2023
Q4
$70K Buy
174
+43
+33% +$17.3K 0.01% 356
2023
Q3
$46K Buy
131
+5
+4% +$1.76K 0.01% 397
2023
Q2
$45K Hold
126
0.01% 403
2023
Q1
$42K Hold
126
0.01% 409
2022
Q4
$36K Hold
126
0.01% 421
2022
Q3
$38K Buy
126
+4
+3% +$1.21K 0.01% 407
2022
Q2
$36K Hold
122
0.01% 394
2022
Q1
$32K Hold
122
0.01% 446
2021
Q4
$27K Buy
122
+10
+9% +$2.21K 0.01% 462
2021
Q3
$20K Sell
112
-14
-11% -$2.5K ﹤0.01% 496
2021
Q2
$25K Hold
126
﹤0.01% 458
2021
Q1
$27K Hold
126
0.01% 411
2020
Q4
$30K Hold
126
0.01% 382
2020
Q3
$34K Hold
126
0.01% 324
2020
Q2
$37K Buy
126
+14
+13% +$4.11K 0.01% 317
2020
Q1
$27K Hold
112
0.01% 340
2019
Q4
$25K Hold
112
0.01% 398
2019
Q3
$19K Hold
112
0.01% 436
2019
Q2
$21K Sell
112
-6
-5% -$1.13K 0.01% 395
2019
Q1
$22K Hold
118
0.01% 379
2018
Q4
$20K Hold
118
0.01% 365
2018
Q3
$23K Hold
118
0.01% 337
2018
Q2
$20K Sell
118
-33
-22% -$5.59K 0.01% 346
2018
Q1
$25K Hold
151
0.01% 312
2017
Q4
$23K Hold
151
0.01% 311
2017
Q3
$23K Buy
151
+6
+4% +$914 0.01% 317
2017
Q2
$19K Hold
145
0.01% 336
2017
Q1
$16K Hold
145
0.01% 347
2016
Q4
$11K Hold
145
0.01% 401
2016
Q3
$13K Hold
145
0.01% 352
2016
Q2
$12K Hold
145
0.01% 369
2016
Q1
$12K Hold
145
0.01% 364
2015
Q4
$18K Buy
145
+45
+45% +$5.59K 0.01% 312
2015
Q3
$10K Hold
100
0.01% 385
2015
Q2
$12K Hold
100
0.01% 366
2015
Q1
$12K Hold
100
0.01% 363
2014
Q4
$7K Buy
+100
New +$7K 0.01% 312